Literature DB >> 8844098

Survey of the fragile X syndrome and the fragile X E syndrome in a special education needs population.

K L Meadows1, D Pettay, J Newman, J Hersey, A E Ashley, S L Sherman.   

Abstract

To begin to understand the population dynamics of the fragile X (FRAXA) mutation and to learn more about the fragile X E (FRAXE) syndrome, we have initiated a surve of children in special needs education programs in the public school system. With respect to the FRAXA syndrome, we found approximately 1/1,000 full mutations among males. No large alleles at the FRAXE locus were observed among 462 individuals. The allele distributions at the two loci among Caucasians and among African Americans were examined as well as the level of heterozygosity. We found a significant difference in the FRAXA allele distribution among the two ethnic groups; the major difference was due to the lack of smaller alleles among the African Americans. No difference was found for the FRAXE allele distribution among the two groups. The level of heterozygosity was less than predicted by the allele distribution at both loci. This is probably due to unidentified large alleles among females with a test result of a single band. Alternatively, this excess may indicate that the population is not at equilibrium.

Entities:  

Mesh:

Year:  1996        PMID: 8844098     DOI: 10.1002/(SICI)1096-8628(19960809)64:2<428::AID-AJMG39>3.0.CO;2-F

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  27 in total

1.  Survey of the fragile X syndrome CGG repeat and the short-tandem-repeat and single-nucleotide-polymorphism haplotypes in an African American population.

Authors:  D C Crawford; C E Schwartz; K L Meadows; J L Newman; L F Taft; C Gunter; W T Brown; N J Carpenter; P N Howard-Peebles; K G Monaghan; S L Nolin; A L Reiss; G L Feldman; E M Rohlfs; S T Warren; S L Sherman
Journal:  Am J Hum Genet       Date:  2000-02       Impact factor: 11.025

2.  Intra-individual stability over time of standardized anti-Mullerian hormone in FMR1 premutation carriers.

Authors:  M A Spath; T B Feuth; E G Allen; A P T Smits; H G Yntema; A Geurts van Kessel; D D M Braat; S L Sherman; C M G Thomas
Journal:  Hum Reprod       Date:  2011-05-15       Impact factor: 6.918

3.  Screening for the fragile X syndrome among the mentally retarded: a clinical study. The Collaborative Fragile X Study Group.

Authors:  B B de Vries; S Mohkamsing; A M van den Ouweland; E Mol; K Gelsema; M van Rijn; A Tibben; D J Halley; H J Duivenvoorden; B A Oostra; M F Niermeijer
Journal:  J Med Genet       Date:  1999-06       Impact factor: 6.318

4.  Genetic counseling for fragile x syndrome: updated recommendations of the national society of genetic counselors.

Authors:  Allyn McConkie-Rosell; Brenda Finucane; Amy Cronister; Liane Abrams; Robin L Bennett; Barbara J Pettersen
Journal:  J Genet Couns       Date:  2005-08       Impact factor: 2.537

5.  Neuropsychological findings from older premutation carrier males and their noncarrier siblings from families with fragile X syndrome.

Authors:  Emily Graves Allen; Jessica E Hunter; Michele Rusin; Jorge Juncos; Gloria Novak; Debra Hamilton; Lisa Shubeck; Krista Charen; Stephanie L Sherman
Journal:  Neuropsychology       Date:  2011-05       Impact factor: 3.295

6.  Women who carry a fragile X premutation are biologically older than noncarriers as measured by telomere length.

Authors:  Igor Albizua; Benjamin L Rambo-Martin; Emily G Allen; Weiya He; Ashima S Amin; Stephanie L Sherman
Journal:  Am J Med Genet A       Date:  2017-09-21       Impact factor: 2.802

7.  Co-occurring diagnoses among FMR1 premutation allele carriers.

Authors:  J E Hunter; J K Rohr; S L Sherman
Journal:  Clin Genet       Date:  2010-01-06       Impact factor: 4.438

8.  Prevalence and phenotype consequence of FRAXA and FRAXE alleles in a large, ethnically diverse, special education-needs population.

Authors:  D C Crawford; K L Meadows; J L Newman; L F Taft; D L Pettay; L B Gold; S J Hersey; E F Hinkle; M L Stanfield; P Holmgreen; M Yeargin-Allsopp; C Boyle; S L Sherman
Journal:  Am J Hum Genet       Date:  1999-02       Impact factor: 11.025

9.  Fragile X-associated primary ovarian insufficiency: evidence for additional genetic contributions to severity.

Authors:  Jessica Ezzell Hunter; Michael P Epstein; Stuart W Tinker; Krista H Charen; Stephanie L Sherman
Journal:  Genet Epidemiol       Date:  2008-09       Impact factor: 2.135

10.  Examination of FMR1 transcript and protein levels among 74 premutation carriers.

Authors:  Emmanuel Peprah; Weiya He; Emily Allen; Tiffany Oliver; Alex Boyne; Stephanie L Sherman
Journal:  J Hum Genet       Date:  2009-11-20       Impact factor: 3.172

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.